AM

Andrew Madin

Merck: 26 patents #332 of 9,382Top 4%
ML Mission Therapeutics Limited: 14 patents #4 of 17Top 25%
Genentech: 8 patents #386 of 2,392Top 20%
AL Astex Therapeutics Limited: 4 patents #72 of 199Top 40%
EC Eisai R&D Management Co.: 2 patents #329 of 817Top 45%
Overall (All Time): #46,579 of 4,157,543Top 2%
54
Patents All Time

Issued Patents All Time

Showing 25 most recent of 54 patents

Patent #TitleCo-InventorsDate
12378249 Isoquinoline compounds and uses thereof Jun Liang, Sushant Malhotra, Rohan Mendonca, Naomi Rajapaksa, Michael Siu +16 more 2025-08-05
12297210 Naphthyridine compounds and uses thereof Terry Kellar, Jun Liang, Sushant Malhotra, Rohan Mendonca, Michael Siu +15 more 2025-05-13
12208088 Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof Sushant Malhotra, Craig Stivala, BinQing Wei, Bryan Chan, Timothy Heffron +8 more 2025-01-28
11993595 Compounds Alison Jones, Mark Ian Kemp, Martin Lee Stockley, Karl Richard Gibson, Gavin Alistair Whitlock 2024-05-28
11958833 Compounds Mark Ian Kemp, Martin Lee Stockley 2024-04-16
11944606 Azaindoles as inhibitors of HPK1 Timothy Heffron, Sushant Malhotra, BinQing Wei, Bryan Chan, Lewis Gazzard +4 more 2024-04-02
11566003 Isoquinolines as inhibitors of HPK1 Bryan Chan, Joy Drobnick, Lewis Gazzard, Timothy Heffron, Jun Liang +16 more 2023-01-31
11472798 Compounds Alison Jones, Mark Ian Kemp, Martin Lee Stockley, Karl Richard Gibson, Gavin Alistair Whitlock 2022-10-18
11414402 Sulfonamide-substituted cyanopyrrolidines with activity as DUB inhibitors Martin Lee Stockley, Mark Ian Kemp, Michael David Woodrow 2022-08-16
11370784 Cyano-substituted heterocycles with activity as inhibitors of USP30 Martin Lee Stockley, Mark Ian Kemp 2022-06-28
11130748 Compounds Mark Ian Kemp, Martin Lee Stockley 2021-09-28
11091488 1-cyano-pyrrolidine derivatives as inhibitors of USP30 Mark Ian Kemp, Martin Lee Stockley 2021-08-17
11084821 Cyanopyrrolidine derivatives with activity as inhibitors of USP30 Martin Lee Stockley, Mark Ian Kemp 2021-08-10
11034692 Naphthyridines as inhibitors of HPK1 Bryan Chan, Blake Daniels, Joy Drobnick, Lewis Gazzard, Timothy Heffron +22 more 2021-06-15
11014912 Cyanopyrrolidine derivatives with activity as inhibitors of USP30 Martin Lee Stockley, Mark Ian Kemp, Michael David Woodrow, Alison Jones 2021-05-25
10952995 Azaindoles as inhibitors of HPK1 Timothy Heffron, Sushant Malhotra, BinQing Wei, Bryan Chan, Lewis Gazzard +4 more 2021-03-23
10774078 Compounds Alison Jones, Mark Ian Kemp, Martin Lee Stockley, Karl Richard Gibson, Gavin Alistair Whitlock 2020-09-15
10683269 2-cyanoisoindoline derivatives for treating cancer Karl Richard Gibson, Alison Jones, Mark Ian Kemp, Martin Lee Stockley, Gavin Alistair Whitlock +2 more 2020-06-16
10640498 Compounds Karl Richard Gibson, Alison Jones, Mark Ian Kemp, Martin Lee Stockley, Gavin Alistair Whitlock +1 more 2020-05-05
10407424 Naphthyridines as inhibitors of HPK1 Bryan Chan, Naomi Rajapaksa, Michael Siu, Craig Stivala, John Tellis +22 more 2019-09-10
10392380 Compounds Alison Jones, Mark Ian Kemp, Martin Lee Stockley, Karl Richard Gibson, Gavin Alistair Whitlock 2019-08-27
9926307 Compounds Alison Jones, Mark Ian Kemp, Martin Lee Stockley, Karl Richard Gibson, Gavin Alistair Whitlock 2018-03-27
9139594 Fused aminodihydropyrimidone derivatives Jose Luis Castro Pineiro, Adrian Hall, Ngoc-Tri Vo 2015-09-22
8895745 Bicyclic heterocyclic compounds as FGFR inhibitors Valerio Berdini, Gilbert Ebai Besong, Owen Callaghan, Maria Grazia Carr, Miles Stuart Congreve +9 more 2014-11-25
8822455 Fused aminodihydrothiazine derivatives Paschalis Dimopoulos, Adrian Hall, Yoichi Kita, Nicola Louise Shuker 2014-09-02